Clinical trial · Observational
Clinical Characteristics of Primary Liver Cancer
A Single Center, Retrospective Clinical Study on the Clinical Characteristics of Primary Liver Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Primary liver cancer (PLC) is the sixth most common malignancy in the world and the third most common cause of malignancy death. In 2020, there were about 905,677 new cases of PLC worldwide, and 830,180 deaths. Despite the availability of a variety of treatments for PLC, the 5-year net survival rate is still only 5% to 30%. How to effectively reduce the disease burden of PLC is a major public health problem that needs to be solved worldwide. The clinical characteristics and prognosis of PLC caused by different pathogenic factors are different. Therefore, it is of great significance to fully identify the risk factors of PLC, be familiar with the clinical characteristics and prognosis of disease development, and understand the relevant monitoring and follow-up strategies for the prevention and treatment of PLC.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Primary Liver Cancer | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- Epidemiological characteristics of overall cohort by liver disease etiology
- timeFrame
- 0 year
- description
- Epidemiological characteristics of overall cohort by liver disease etiology, including HBV, HCV, NAFLD, ALD and others.
- measure
- Clinical characteristics of overall cohort by liver disease etiology
- timeFrame
- 0 year
- description
- Clinical characteristics of overall cohort by liver disease etiology, including HBV, HCV, NAFLD, ALD and others.
Secondary outcomes (2)
- measure
- Survival rates of overall cohort and different etiologies
- timeFrame
- 1 year, 3years，10 years
- description
- 1-year, 3-year, 5-year, and 10-year survival rates for overall cohort and different etiologies
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. 18 years or older; 2. initial diagnosis of primary liver cancer based on enhanced CT or enhanced MRI or pathology Exclusion Criteria: 1. other types of malignant tumors; 2. mental illness, severe cardiopulmonary dysfunction, severe renal insufficiency, serious infection and cerebrovascular accident; 3. received liver transplant or other organ transplant.
References
Publications (0)
Data not yet available